|
Re: I'm ready for anything at this point...
|
2
|
Resverlogix Corp.
|
Dec 12, 2018 01:21PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
2
|
Resverlogix Corp.
|
Apr 06, 2022 06:57AM
|
|
Re: I'm anxiously awaiting the next short interest update...
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 03:11PM
|
|
Re: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
2
|
Resverlogix Corp.
|
Mar 05, 2023 09:10AM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
2
|
Resverlogix Corp.
|
Aug 15, 2022 01:19PM
|
|
Re: Corona- COVID-19
|
2
|
Resverlogix Corp.
|
Mar 05, 2020 06:23PM
|
|
Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Oct 23, 2023 05:17PM
|
|
Re: Constellation Pharma
|
2
|
Resverlogix Corp.
|
Jul 05, 2020 01:26PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 25, 2022 07:18AM
|
|
Re: Over 700K traded in Canada today....
|
2
|
Resverlogix Corp.
|
Oct 25, 2019 06:32PM
|
|
Re: OTC Short interest up 0.88%/around 7k shrs to 767,637 as of the end of Feb
|
2
|
Resverlogix Corp.
|
Mar 11, 2022 02:09PM
|
|
Re: ZHCLF up 290% to $0.16...question
|
2
|
Zenith Epigenetics
|
Dec 11, 2020 04:26PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
2
|
Zenith Epigenetics
|
May 17, 2022 11:21AM
|
|
Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 07:45PM
|
|
Re: although pathetic volume's
|
2
|
Resverlogix Corp.
|
May 25, 2024 07:43AM
|
|
Re: ZHCLF up 290% to $0.16...question
|
2
|
Zenith Epigenetics
|
Dec 11, 2020 04:38PM
|
|
Re: Number of outstanding warrants + impact
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 09:01AM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 10, 2021 11:40AM
|
|
Re: The problem...as I see it
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 12:55PM
|
|
Re: Can Hepalink afford US rights?
|
2
|
Resverlogix Corp.
|
Feb 05, 2019 06:13AM
|
